These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 22297680)
1. Inhibition of eNOS phosphorylation mediates endothelial dysfunction in renal failure: new effect of asymmetric dimethylarginine. Kajimoto H; Kai H; Aoki H; Yasuoka S; Anegawa T; Aoki Y; Ueda S; Okuda S; Imaizumi T Kidney Int; 2012 Apr; 81(8):762-8. PubMed ID: 22297680 [TBL] [Abstract][Full Text] [Related]
2. ADMA and NOS regulation in chronic renal disease: beyond the old rivalry for l-arginine. Dobrian AD Kidney Int; 2012 Apr; 81(8):722-4. PubMed ID: 22460653 [TBL] [Abstract][Full Text] [Related]
3. Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients. Pasini AF; Garbin U; Stranieri C; Boccioletti V; Mozzini C; Manfro S; Pasini A; Cominacini M; Cominacini L Am J Hypertens; 2008 Nov; 21(11):1251-7. PubMed ID: 18772860 [TBL] [Abstract][Full Text] [Related]
4. Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: Effect of combination with oral L-arginine. Böger GI; Rudolph TK; Maas R; Schwedhelm E; Dumbadze E; Bierend A; Benndorf RA; Böger RH J Am Coll Cardiol; 2007 Jun; 49(23):2274-82. PubMed ID: 17560293 [TBL] [Abstract][Full Text] [Related]
5. Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease. Tatematsu S; Wakino S; Kanda T; Homma K; Yoshioka K; Hasegawa K; Sugano N; Kimoto M; Saruta T; Hayashi K J Am Soc Nephrol; 2007 Mar; 18(3):741-9. PubMed ID: 17267746 [TBL] [Abstract][Full Text] [Related]
6. Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice. Desai A; Zhao Y; Warren JS Nephrol Dial Transplant; 2008 May; 23(5):1513-20. PubMed ID: 18204093 [TBL] [Abstract][Full Text] [Related]
7. Dimethylarginine dimethylaminohydrolase inhibition and asymmetric dimethylarginine accumulation contribute to endothelial dysfunction in rats exposed to glycosylated protein: effects of aminoguanidine. Yin QF; Fu SH; He P; Xiong Y Atherosclerosis; 2007 Jan; 190(1):53-61. PubMed ID: 16533509 [TBL] [Abstract][Full Text] [Related]
8. Chronic renal failure alters endothelial function in cerebral circulation in mice. Bugnicourt JM; Da Silveira C; Bengrine A; Godefroy O; Baumbach G; Sevestre H; Bode-Boeger SM; Kielstein JT; Massy ZA; Chillon JM Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H1143-52. PubMed ID: 21705678 [TBL] [Abstract][Full Text] [Related]
9. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress. Suda O; Tsutsui M; Morishita T; Tasaki H; Ueno S; Nakata S; Tsujimoto T; Toyohira Y; Hayashida Y; Sasaguri Y; Ueta Y; Nakashima Y; Yanagihara N Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1682-8. PubMed ID: 15217805 [TBL] [Abstract][Full Text] [Related]
13. AVE3085 protects coronary endothelium from the impairment of asymmetric dimethylarginine by activation and recoupling of eNOS. Xue HM; Yu CM; Underwood MJ; Huang JH; Yang Q Cardiovasc Drugs Ther; 2012 Oct; 26(5):383-92. PubMed ID: 22890813 [TBL] [Abstract][Full Text] [Related]
14. Asymmetric Dimethylarginine Limits the Efficacy of Simvastatin Activating Endothelial Nitric Oxide Synthase. Hsu CP; Zhao JF; Lin SJ; Shyue SK; Guo BC; Lu TM; Lee TS J Am Heart Assoc; 2016 Apr; 5(4):e003327. PubMed ID: 27091343 [TBL] [Abstract][Full Text] [Related]
15. Basal release of nitric oxide in the mesenteric artery in portal hypertension and cirrhosis: role of dimethylarginine dimethylaminohydrolase. Serna E; Mauricio MD; Lluch P; Segarra G; Cortina B; Lluch S; Medina P J Gastroenterol Hepatol; 2013 May; 28(5):880-6. PubMed ID: 23302093 [TBL] [Abstract][Full Text] [Related]
16. Vascular peroxidase 1 up regulation by angiotensin II attenuates nitric oxide production through increasing asymmetrical dimethylarginine in HUVECs. Peng H; Chen L; Huang X; Yang T; Yu Z; Cheng G; Zhang G; Shi R J Am Soc Hypertens; 2016 Sep; 10(9):741-751.e3. PubMed ID: 27475679 [TBL] [Abstract][Full Text] [Related]
17. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway. Tan B; Jiang DJ; Huang H; Jia SJ; Jiang JL; Hu CP; Li YJ Vascul Pharmacol; 2007 May; 46(5):338-45. PubMed ID: 17293168 [TBL] [Abstract][Full Text] [Related]
18. Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function. Cardounel AJ; Cui H; Samouilov A; Johnson W; Kearns P; Tsai AL; Berka V; Zweier JL J Biol Chem; 2007 Jan; 282(2):879-87. PubMed ID: 17082183 [TBL] [Abstract][Full Text] [Related]
19. Protective effects of kaempferol against endothelial damage by an improvement in nitric oxide production and a decrease in asymmetric dimethylarginine level. Xiao HB; Jun-Fang ; Lu XY; Chen XJ; Chao-Tan ; Sun ZL Eur J Pharmacol; 2009 Aug; 616(1-3):213-22. PubMed ID: 19549512 [TBL] [Abstract][Full Text] [Related]
20. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis. Antoniades C; Shirodaria C; Leeson P; Antonopoulos A; Warrick N; Van-Assche T; Cunnington C; Tousoulis D; Pillai R; Ratnatunga C; Stefanadis C; Channon KM Eur Heart J; 2009 May; 30(9):1142-50. PubMed ID: 19297385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]